Emilio Emini - 11 Jun 2025 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)

Reporting relationship: Director
Issuer ticker: DVAX
Reported as of: 11 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Jun 2025, 17:47:27 UTC
Prior SEC filing: 05 Feb 2025
Next SEC filing: 10 Feb 2026
Source filing: View source filing
Reporting owner signature: Emilio Emini, by /s/ Trevor Dutcher, Attorney-in-Fact

Key filing fact

Emilio Emini filed Form 4 for DYNAVAX TECHNOLOGIES CORP (DVAX) on 13 Jun 2025.

Key facts

This page summarizes Emilio Emini's Form 4 filing for DYNAVAX TECHNOLOGIES CORP (DVAX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 13 Jun 2025, 17:47.

Change

Previous filing in this sequence was filed on 05 Feb 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002054163 Primary reporting owner

Emini Emilio

Relationship: Director
Address: C/O DYNAVAX TECHNOLOGIES, 2100 POWELL STREET, SUITE 720, EMERYVILLE
Signature: Emilio Emini, by /s/ Trevor Dutcher, Attorney-in-Fact
Signature date: 13 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DVAX transaction

Common Stock

Award

Transaction value: $0
Shares: +1,439
Change %: +17%
Price: $0.000000
Shares after: 10,075
Date: 11 Jun 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DVAX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +7,125
Change %
Price: $0.000000
Shares after: 7,125
Date: 11 Jun 2025
Ownership: Direct
Underlying class: Commont Stock
Underlying amount: 7,125
Exercise price: $10.18
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of DVAX Common Stock. The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. The release of RSU shares shall be mandatorily deferred six months and one day after the Reporting Person no longer provides services to the Company.

Footnote F2

This option grant fully vests and becomes exercisable one year from date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date.